Matches in Nanopublications for { ?s ?p "[IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP531030.RAV72goRKOCLzDieZyJ5coqylzfuTkzmA5Z20rbj3aWNk130_assertion description "[IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531030.RAV72goRKOCLzDieZyJ5coqylzfuTkzmA5Z20rbj3aWNk130_provenance.
- NP67643.RAChNjvvURYbyMfZLzlJZy6lZ7ud64zljasycyZFyh1oE130_assertion description "[IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP67643.RAChNjvvURYbyMfZLzlJZy6lZ7ud64zljasycyZFyh1oE130_provenance.
- NP728687.RAgkSQRDENyzKs4f5beAh3zfwa1YSu4sNcuQ9Q5Md6ySw130_assertion description "[IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP728687.RAgkSQRDENyzKs4f5beAh3zfwa1YSu4sNcuQ9Q5Md6ySw130_provenance.
- assertion description "[IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP730083.RAUVfd0BfUP2qPIbuRprEJpzm-wQe72aO3dkd8o4K-jos130_assertion description "[IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP730083.RAUVfd0BfUP2qPIbuRprEJpzm-wQe72aO3dkd8o4K-jos130_provenance.
- assertion description "[IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP859686.RAsT5Vf3mxgjrq9W5kqcujxUO0NuY6JNJ2HRoDQWU9xqM130_assertion description "[IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP859686.RAsT5Vf3mxgjrq9W5kqcujxUO0NuY6JNJ2HRoDQWU9xqM130_provenance.